Sofinnova Ventures

edit

Since 1974, Sofinnova Ventures has partnered with entrepreneurs to secure initial funding, build successful teams, win key customers, and navigate acquisitions and IPOs.

Sofinnova Ventures invests in Life Science and Technology start-ups. Their professionals are seasoned business operators, possessing deep domain and investment expertise. They know how to help entrepreneurs build successful, global businesses.

Milestones

edit

• 
  Sofinnova Ventures invested in UPEK. (10/09)
  Posted 10/15/09 at 5:04pm
• 
  Sofinnova Ventures invested in Alvine Pharmaceuticals. (9/15/09)
  Posted 9/21/09 at 7:11am
• 
  Sofinnova Ventures invested in Intellikine. (7/22/09)
  Posted 7/28/09 at 1:25pm
• 
  Sofinnova Ventures invested in Stentys. (7/13/09)
  Posted 7/13/09 at 1:09pm
• 
  Sofinnova Ventures invested in Hyperion Therapeutics. (6/30/09)
  Posted 6/30/09 at 3:34pm
• 
  Sofinnova Ventures invested in CoAxia. (6/24/09)
  Posted 6/24/09 at 7:44am
• 
  Sofinnova Ventures invested in blueKiwi Software. (6/22/09)
  Posted 7/6/09 at 5:22pm
• 
  Sofinnova Ventures invested in Streamezzo. (5/13/09)
  Posted 7/7/09 at 12:18pm
• 
  Sofinnova Ventures invested in Marinus Pharmaceuticals. (5/3/09)
  Posted 6/24/09 at 1:40pm
• 
  Sofinnova Ventures invested in KaloBios Pharmaceuticals. (12/22/08)
  Posted 6/14/09 at 11:02pm
• 
  Sofinnova Ventures invested in Taptu. (12/18/08)
  Posted 12/18/08 at 1:32pm
• 
  Sofinnova Ventures invested in Catalyst Biosciences. (12/3/08)
  Posted 6/23/09 at 10:50am
• 
  Sofinnova Ventures invested in Crocus Technology. (10/3/08)
  Posted 7/7/09 at 3:15pm
• 
  Sofinnova Ventures invested in InteKrin. (8/4/08)
  Posted 6/25/09 at 7:47pm
• 
  Sofinnova Ventures invested in Streamezzo. (12/1/07)
  Posted 12/18/07 at 1:51am
• 
  Sofinnova Ventures invested in Hyperion Therapeutics. (9/5/07)
  Posted 9/17/09 at 8:25am

Investments

Videos

Sources

1. Upek raises $6.2M for fingerprinting software (deals.venturebeat.com) [edit]
2. Alvine gobbles $21.5M to treat gastrointestinal disease (deals.venturebeat.com) [edit]
3. Intellikine, Inc.: Series B $51M (onbiovc.com) [edit]
4. Stentys, SAS: Series B $4.2M (onbiovc.com) [edit]
5. Hyperion lands $60M VC round (fiercebiotech.com) [edit]
6. CoAxia, Inc.: Series D $21.5M (onbiovc.com) [edit]
7. Capital Report Index [edit]
8. Streamezzo Raises EUR4M in Investment Round and Welcomes Innovacom as New Investor (journalist-association.eu) [edit]
9. Marinus Pharmaceuticals, Inc.: Series B $20M (onbiovc.com) [edit]
10. KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million (kalobios.com) [edit]
11. Taptu closes £6.45m Series B round (uk.techcrunch.com) [edit]
12. Catalyst Biosciences Raises $40 Million in Series C Financing (fiercebiotech.com) [edit]
13. Crocus Technology Receives 11.5M Euros in Second Round Funding (edageek.com) [edit]
14. InteKrin raises $18.5M for continued work on diabetes drug (deals.venturebeat.com) [edit]
15. webitpr.com [edit]
16. Hyperion Therapeutics raises $40M against GI and kidney disease (deals.venturebeat.com) [edit]
17. DiObex, a metabolic disease treatment co., raises $24M (deals.venturebeat.com) [edit]
18. Alvine Pharma raises nearly $8M from Prospect, Sofinnova (deals.venturebeat.com) [edit]
19. about.blyk.com [edit]